Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Fresenius Medical Care Corp (FMS)

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Zacks Analyst Blog Highlights: ResMed, Invacare, Fresenius, Henry Schein and Quest Diagnostics

The Zacks Analyst Blog Highlights: ResMed, Invacare, Fresenius, Henry Schein and Quest Diagnostics

DGX : 124.38 (-0.06%)
FMS : 41.85 (-0.95%)
RMD : 218.80 (+1.52%)
HSIC : 68.96 (-0.25%)
IVC : 9.92 (-0.10%)
Is Fresenius (FMS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.85 (-0.95%)
4 MedTech Underperformers Poised for a Turnaround in 2021

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

DGX : 124.38 (-0.06%)
FMS : 41.85 (-0.95%)
RMD : 218.80 (+1.52%)
HSIC : 68.96 (-0.25%)
IVC : 9.92 (-0.10%)
CSII : 46.09 (-1.20%)
Is Fresenius (FMS) a Solid Growth Stock? 3 Reasons to Think " Yes "

Fresenius (FMS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

FMS : 41.85 (-0.95%)
Are Investors Undervaluing Fresenius (FMS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.85 (-0.95%)
Here's Why You Should Retain Fresenius Medical (FMS) Stock

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

FMS : 41.85 (-0.95%)
MMSI : 58.09 (+0.48%)
ALGN : 521.52 (-2.35%)
TMO : 519.62 (+0.98%)
Is Fresenius Medical Care (FMS) a Good Stock to Pick Now?

Is Fresenius Medical Care (FMS) a great pick from the value investor's perspective right now? Read on to know more.

FMS : 41.85 (-0.95%)
Fresenius Medical (FMS) Stock Gains 5.6% on Q3 Earnings Beat

Fresenius Medical's (FMS) third-quarter earnings benefit from stable segmental performance.

ANGO : 18.02 (-0.99%)
FMS : 41.85 (-0.95%)
ALGN : 521.52 (-2.35%)
TMO : 519.62 (+0.98%)
Here's Why You Should Retain Fresenius Medical Stock Now

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

FMS : 41.85 (-0.95%)
BSX : 36.58 (-1.22%)
TMO : 519.62 (+0.98%)
BIOL : 1.0300 (-0.96%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.85 (-0.95%)
FMS vs. SMLR: Which Stock Is the Better Value Option?

FMS vs. SMLR: Which Stock Is the Better Value Option?

FMS : 41.85 (-0.95%)
SMLR : 90.5000 (-0.55%)
The Zacks Analyst Blog Highlights: FMS, HOLX and TMO

The Zacks Analyst Blog Highlights: FMS, HOLX and TMO

HOLX : 75.40 (-0.40%)
FMS : 41.85 (-0.95%)
TMO : 519.62 (+0.98%)
3 MedTech Outperformers to Grab Amid September Pullback

Let's grab these three stocks that have continued to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

HOLX : 75.40 (-0.40%)
FMS : 41.85 (-0.95%)
TMO : 519.62 (+0.98%)
Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

Fresenius Medical Care, the world's leading provider of dialysis products and services, today announced the launch of the organization's first World Patient Safety Day initiative to raise awareness of...

FMS : 41.85 (-0.95%)
5 Top PEG-Driven Value Stocks Amid Coronavirus-Led Selloffs

While searching for a suitable value investment option, investors are unlikely to consider PEG ratio among a number of other popular value metrics.

WHR : 206.57 (+4.22%)
FMS : 41.85 (-0.95%)
RBC : 130.87 (-2.04%)
HBI : 15.60 (+0.13%)
Buy 4 Beaten-Down MedTech Value Stocks Amid September Selloffs

Here are some dirt-cheap MedTech value stocks which have been battered by the pandemic-led market meltdown and can be considered for long-term gains.

DVA : 118.50 (-0.91%)
FMS : 41.85 (-0.95%)
RMD : 218.80 (+1.52%)
MYGN : 26.20 (-1.61%)
AMN : 74.97 (-0.15%)
NXGN : 22.96 (+0.04%)
CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day

CHDN, AMC, FMS, OMI and TMO as Zacks Bull and Bear of the Day

OMI : 28.39 (+2.97%)
FMS : 41.85 (-0.95%)
TMO : 519.62 (+0.98%)
CHDN : 206.02 (-3.89%)
AMC : 4.52 (+28.77%)
3 MedTech Outperformers to Grab Amid Coronavirus Pandemic

Let's grab these three stocks that have shown tremendous promise amid the coronavirus pandemic.

OMI : 28.39 (+2.97%)
FMS : 41.85 (-0.95%)
ABMD : 349.96 (+0.59%)
TMO : 519.62 (+0.98%)
The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS

The Zacks Analyst Blog Highlights: TVTY, NXGN, ELMD and FMS

FMS : 41.85 (-0.95%)
ELMD : 10.07 (+0.20%)
TVTY : 21.90 (-0.27%)
NXGN : 22.96 (+0.04%)
Should Value Investors Buy Fresenius (FMS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

FMS : 41.85 (-0.95%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar